Patents by Inventor Monique Berwaer

Monique Berwaer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions for the controlled release of active substances
    Patent number: 7083807
    Abstract: The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising a) the said at least one active substance, b) between 5 and 60% by weight, relative to the total weight of the composition, of at least one excipient, selected from inert matrices, hydrophilic matrices, lipid matrices, mixtures of inert matrices and of lipid matrices, mixtures of hydrophilic matrices and of inert matrices, with the exception of mixtures comprising a polyacrylic acid and at least one hydrophilic matrix of the cellulose type; c) between 5 and 50% by weight, relative to the total weight of the composition, of at least one alkalinizing agent soluble in an aqueous phase under physiological pH conditions, selected from alkali or alkaline-earth metal hydroxidcs, carbonates, bicarbonates and phosphates, sodium borate as well as the basic salts of organic acids.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: August 1, 2006
    Assignee: UCB, S.A.
    Inventors: Domenico Fanara, Monique Berwaer, Anne Bouquelle, Michel Deleers
  • Tablet comprising efletirizine and pseudoephedrine
    Publication number: 20060122194
    Abstract: The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
    Type: Application
    Filed: November 12, 2003
    Publication date: June 8, 2006
    Applicant: UCB Farchim S.A.
    Inventors: Monique Berwaer, Anthony Guichaux, Serge Cuypers, Michel Deleers, Domenico Fanara
  • Tablet comprising cetirizine and pseudoephedrine
    Patent number: 7014867
    Abstract: The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: March 21, 2006
    Assignee: UCB Farchim SA
    Inventors: Domenico Fanara, Anthony Guichaux, Monique Berwaer, Michel Deleers
  • Tablet comprising cetirizine and pseudoephedrine
    Publication number: 20060034928
    Abstract: The present invention concerns a tablet comprising two distinct segments. More particularly, the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
    Type: Application
    Filed: October 18, 2005
    Publication date: February 16, 2006
    Inventors: Domenico Fanara, Anthony Guichaux, Monique Berwaer, Michel Deleers
  • Pharmaceutical formulations with modified release
    Publication number: 20050171119
    Abstract: The invention relates to a pharmaceutical composition which can be administered orally, containing efletirizine as active principle, and combining a fraction which allows immediate release and a fraction which allows prolonged release.
    Type: Application
    Filed: January 8, 2003
    Publication date: August 4, 2005
    Applicant: UCB, S.A.
    Inventors: Monique Berwaer, Michel Deleers, Domenico Fanara, Anthony Guichaux
  • Formulations
    Publication number: 20050038039
    Abstract: The present invention relates to pharmaceutical compositions for oral administration of active compounds.
    Type: Application
    Filed: January 14, 2003
    Publication date: February 17, 2005
    Inventors: Domenico Fanara, Monique Berwaer, Anthony Guichaux, Michel Deleers
  • Tablet comprising cetirizine and pseudoephedrine
    Publication number: 20040170690
    Abstract: The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders.
    Type: Application
    Filed: December 19, 2003
    Publication date: September 2, 2004
    Inventors: Domenico Fanara, Anthony Guichaux, Monique Berwaer, Michel Deleers
  • Pharmaceutical compositions for the controlled release of active substances
    Publication number: 20040086563
    Abstract: The present invention is directed a pharmaceutical composition which can be administered orally, allowing for the controlled release of at least one active substance. The composition includes at least one active substance, between 5 and 60% by weight, relative to the total weight of the composition, of at least one excipient, selected from the group consisting of inert matrices, hydrophilic matrices, lipid matrices, mixtures of inert matrices and of lipid matrices, and mixtures of hydrophilic matrices and of inert matrices, with the exception of mixtures comprising a polyacrylic acid and at least one hydrophilic matrix of the cellulose type; and between and 14.3% by weight, relative to the total weight of the composition, of at least one alkalinizing agent soluble in an aqueous phase under physiological pH conditions, selected from the group consisting of alkali or alkaline-earth metal hydroxides, carbonates, bicarbonates, phosphates, sodium borate and basic salts of organic acids.
    Type: Application
    Filed: June 27, 2003
    Publication date: May 6, 2004
    Inventors: Domenico Fanara, Monique Berwaer, Anne Bouquelle, Michel Delleers
  • Pharmaceutical compositions for controlled release of active substances
    Patent number: 6699502
    Abstract: The present invention is directed a pharmaceutical composition which can be administered orally, allowing for the controlled release of at least one active substance. The composition includes at least one active substance, between 5 and 60% by weight, relative to the total weight of the composition, of at least one excipient, selected from inert matrices, hydrophilic matrices, lipid matrices, mixtures of inert matrices and of lipid matrices, and mixtures of hydrophilic matrices and of inert matrices, with the exception of mixtures including a polyacrylic acid and at least one hydrophilic matrix of the cellulose type; and between 5 and 50% by weight, relative to the total weight of the composition, of at least one alkalinizing agent soluble in an aqueous phase under physiological pH conditions, selected from alkali or alkaline-earth metal hydroxides, carbonates, bicarbonates, phosphates, sodium borate and basic salts of organic acids.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: March 2, 2004
    Assignee: UCB, S.A.
    Inventors: Domenico Fanara, Monique Berwaer, Anne Bouquelle, Michel Deleers
  • Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
    Patent number: 6455533
    Abstract: The invention concerns pharmaceutical compositions for oral administration, comprising an active substance belonging to the family of substituted benzhydrylpiperazines and at least a cyclodextrin.
    Type: Grant
    Filed: December 23, 1999
    Date of Patent: September 24, 2002
    Assignee: UCB, S.A.
    Inventors: Domenico Fanara, Monique Berwaer, Philippe Nolf, Henri Vranckx, Michel Deleers
  • Pharmaceutical compositions for the controlled release of active substances
    Publication number: 20020110596
    Abstract: The invention relates to pharmaceutical compositions which can be administrated orally, allowing the controlled release of at least one active substance comprising
    Type: Application
    Filed: January 28, 2002
    Publication date: August 15, 2002
    Inventors: Domenico Fanara, Monique Berwaer, Ann Bouquelle, Michel Deleers
  • PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION, COMPRISING AN ACTIVE SUBSTANCE AND A CYCLODEXTRIN
    Publication number: 20020032217
    Abstract: The invention concerns pharmaceutical compositions for oral administration, comprising an active substance belonging to the family of substituted benzhydrylpiperazines and at least a cyclodextrin.
    Type: Application
    Filed: December 23, 1999
    Publication date: March 14, 2002
    Inventors: DOMENICO FANARA, MONIQUE BERWAER, PHILIPPE NOLF, HENRI VRANCKX, MICHEL DELEERS
  • Pseudopolymorphic forms of 2-[2-[4-[Bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
    Patent number: 6335331
    Abstract: The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride monohydrate. It also relates to processes for the preparation of these pseudopolymorphic forms and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: January 1, 2002
    Assignee: UCB, S.A.
    Inventors: Monique Berwaer, Guy Bodson, Michel Deleers, Charles Dogimont, Domenico Fanara, Jacques Timmermans
  • Pseudopolymorphic forms of 2-[2-[4-[Bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
    Publication number: 20010021712
    Abstract: The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis(4- fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-l-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[4-[bis(4-fluorophenyl)methyl]-l-piperazinyl]ethoxy]acetic acid dihydrochloride monohydrate. It also relates to processes for the preparation of these pseudopolymorphic forms and to pharmaceutical compositions containing them.
    Type: Application
    Filed: March 8, 2001
    Publication date: September 13, 2001
    Inventors: Monique Berwaer, Guy Bodson, Michel Deleers, Charles Dogimont, Domenico Fanara, Jacques Timmermans
  • Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
    Patent number: 6262057
    Abstract: The present invention relates to new pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, namely, anhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[-bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride monohydrate. It also relates to processes for the preparation of these pseudopolymorphic forms and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: July 17, 2001
    Assignee: UCB, S.A.
    Inventors: Monique Berwaer, Guy Bodson, Michel Deleers, Charles Dogimont, Domenico Fanara, Jacques Timmermans